Market Cap 1.94B
Revenue (ttm) 2.01B
Net Income (ttm) -99.07M
EPS (ttm) N/A
PE Ratio 11.64
Forward PE 13.33
Profit Margin -4.92%
Debt to Equity Ratio 0.68
Volume 1,024,500
Avg Vol 839,988
Day's Range N/A - N/A
Shares Out 85.88M
Stochastic %K 97%
Beta 1.20
Analysts Sell
Price Target $22.67

Company Profile

Pediatrix Medical Group, Inc., together with its subsidiaries, provides newborn, maternal-fetal, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians. The company also provides maternal-fetal care services, including inpatient and office-ba...

Industry: Medical Care Facilities
Sector: Healthcare
Phone: 954 384 0175
Address:
1301 Concord Terrace, Sunrise, United States
kshonstocks
kshonstocks Nov. 14 at 8:16 PM
$MD v good ibd https://research.investors.com/stock-quotes/nyse-pediatrix-medical-md.htm
0 · Reply
TheUnmaker
TheUnmaker Nov. 11 at 4:10 PM
$BB Why would I ever sell? Just buy more! $MD $NVDA $MSFT $AMZN
0 · Reply
JarvisFlow
JarvisFlow Nov. 10 at 5:04 PM
Truist Securities updates rating for Pediatrix Medical Group ( $MD ) to Hold, target set at 17 → 24.
0 · Reply
SuperGreenToday
SuperGreenToday Nov. 6 at 10:07 PM
$MD Share Price: $21.83 Contract Selected: May 15, 2026 $20 Calls Buy Zone: $2.25 – $2.78 Target Zone: $4.27 – $5.22 Potential Upside: 79% ROI Time to Expiration: 189 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
ZacksResearch
ZacksResearch Nov. 6 at 5:49 PM
$MD beat Q3 earnings even with softer revenues 💪 Lower expenses and improved patient acuity boosted profitability, helping results top estimates. See the full Q3 snapshot here 👉 https://www.zacks.com/stock/news/2787093/pediatrix-medical-q3-earnings-beat-estimates-on-declining-expenses?cid=sm-stocktwits-2-2787093-teaser-19889&ADID=SYND_STOCKTWITS_TWEET_2_2787093_TEASER_19889
0 · Reply
ZacksResearch
ZacksResearch Nov. 6 at 4:49 PM
$MD beats Q3 estimates with a 52.3% EPS surge — what's behind the quarterly results? 🚀 📈 Higher collection activity and improved patient acuity 🛠️ Operating expenses down 11% year over year 💸 Share repurchase program update Full details here 👉 https://www.zacks.com/stock/news/2787093/pediatrix-medical-q3-earnings-beat-estimates-on-declining-expenses?cid=sm-stocktwits-2-2787093-body-19863&ADID=SYND_STOCKTWITS_TWEET_2_2787093_BODY_19863
0 · Reply
IN0V8
IN0V8 Nov. 6 at 5:41 AM
$MD Mizuho raises target price to $21 from $18 UBS raises target price to $23 from $16.50
0 · Reply
JarvisFlow
JarvisFlow Nov. 5 at 11:18 PM
UBS updates rating for Pediatrix Medical Group ( $MD ) to Neutral, target set at 16.5 → 23.
0 · Reply
phatsuit
phatsuit Nov. 4 at 3:30 PM
$MD lfg!!!
0 · Reply
AEYE_NextSpace_LUNR
AEYE_NextSpace_LUNR Nov. 3 at 11:29 PM
$FGL $MD $PRLD $TCMD $TERN ❌👎🏻👎🏻👎🏻 WRONG TERN UP ONLY 2% on PUMPER PURCHASES. NICE TRY. I TOLD YOU CLOWNS
1 · Reply
Latest News on MD
Pediatrix Medical Group Reports Third Quarter Results

Nov 3, 2025, 6:00 AM EST - 12 days ago

Pediatrix Medical Group Reports Third Quarter Results


Pediatrix Medical Group Reports Second Quarter Results

Aug 5, 2025, 6:00 AM EDT - 3 months ago

Pediatrix Medical Group Reports Second Quarter Results


Pediatrix Board Appoints Kurt D. Newman, M.D.

Jul 1, 2025, 4:05 PM EDT - 4 months ago

Pediatrix Board Appoints Kurt D. Newman, M.D.


Pediatrix Medical Group Reports First Quarter Results

May 6, 2025, 6:00 AM EDT - 6 months ago

Pediatrix Medical Group Reports First Quarter Results


Top 3 Health Care Stocks You May Want To Dump In February

Feb 20, 2025, 3:50 PM EST - 9 months ago

Top 3 Health Care Stocks You May Want To Dump In February

LUNG SWTX


Pediatrix Medical Group Reports Fourth Quarter Results

Feb 20, 2025, 6:00 AM EST - 9 months ago

Pediatrix Medical Group Reports Fourth Quarter Results


Pediatrix Board Appoints Sylvia Young as Independent Director

May 4, 2023, 4:05 PM EDT - 2 years ago

Pediatrix Board Appoints Sylvia Young as Independent Director


James D. Swift, M.D., Elected to Pediatrix Board of Directors

Mar 8, 2023, 5:36 PM EST - 2 years ago

James D. Swift, M.D., Elected to Pediatrix Board of Directors


Pediatrix Announces Leadership Transitions

Dec 15, 2022, 4:41 PM EST - 3 years ago

Pediatrix Announces Leadership Transitions


Pediatrix: These 5 Graphs Suggest It's A Buy

Sep 29, 2022, 12:52 PM EDT - 3 years ago

Pediatrix: These 5 Graphs Suggest It's A Buy


Pediatrix Medical Group Comments on No Surprises Act Final Rule

Aug 22, 2022, 3:00 PM EDT - 3 years ago

Pediatrix Medical Group Comments on No Surprises Act Final Rule


Pediatrix: Seeking 46% Return Objective As Speculative Buy

Jul 14, 2022, 12:06 AM EDT - 3 years ago

Pediatrix: Seeking 46% Return Objective As Speculative Buy


kshonstocks
kshonstocks Nov. 14 at 8:16 PM
$MD v good ibd https://research.investors.com/stock-quotes/nyse-pediatrix-medical-md.htm
0 · Reply
TheUnmaker
TheUnmaker Nov. 11 at 4:10 PM
$BB Why would I ever sell? Just buy more! $MD $NVDA $MSFT $AMZN
0 · Reply
JarvisFlow
JarvisFlow Nov. 10 at 5:04 PM
Truist Securities updates rating for Pediatrix Medical Group ( $MD ) to Hold, target set at 17 → 24.
0 · Reply
SuperGreenToday
SuperGreenToday Nov. 6 at 10:07 PM
$MD Share Price: $21.83 Contract Selected: May 15, 2026 $20 Calls Buy Zone: $2.25 – $2.78 Target Zone: $4.27 – $5.22 Potential Upside: 79% ROI Time to Expiration: 189 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
ZacksResearch
ZacksResearch Nov. 6 at 5:49 PM
$MD beat Q3 earnings even with softer revenues 💪 Lower expenses and improved patient acuity boosted profitability, helping results top estimates. See the full Q3 snapshot here 👉 https://www.zacks.com/stock/news/2787093/pediatrix-medical-q3-earnings-beat-estimates-on-declining-expenses?cid=sm-stocktwits-2-2787093-teaser-19889&ADID=SYND_STOCKTWITS_TWEET_2_2787093_TEASER_19889
0 · Reply
ZacksResearch
ZacksResearch Nov. 6 at 4:49 PM
$MD beats Q3 estimates with a 52.3% EPS surge — what's behind the quarterly results? 🚀 📈 Higher collection activity and improved patient acuity 🛠️ Operating expenses down 11% year over year 💸 Share repurchase program update Full details here 👉 https://www.zacks.com/stock/news/2787093/pediatrix-medical-q3-earnings-beat-estimates-on-declining-expenses?cid=sm-stocktwits-2-2787093-body-19863&ADID=SYND_STOCKTWITS_TWEET_2_2787093_BODY_19863
0 · Reply
IN0V8
IN0V8 Nov. 6 at 5:41 AM
$MD Mizuho raises target price to $21 from $18 UBS raises target price to $23 from $16.50
0 · Reply
JarvisFlow
JarvisFlow Nov. 5 at 11:18 PM
UBS updates rating for Pediatrix Medical Group ( $MD ) to Neutral, target set at 16.5 → 23.
0 · Reply
phatsuit
phatsuit Nov. 4 at 3:30 PM
$MD lfg!!!
0 · Reply
AEYE_NextSpace_LUNR
AEYE_NextSpace_LUNR Nov. 3 at 11:29 PM
$FGL $MD $PRLD $TCMD $TERN ❌👎🏻👎🏻👎🏻 WRONG TERN UP ONLY 2% on PUMPER PURCHASES. NICE TRY. I TOLD YOU CLOWNS
1 · Reply
Godwins26
Godwins26 Nov. 3 at 11:04 PM
$FGL Biggest runner after hours still highest 😊 $PRLD $TERN $TCMD $MD
0 · Reply
RunnerSignals
RunnerSignals Nov. 3 at 9:10 PM
Wild Swings Hit the Tape $RAY.X $MSAI $MD flying high while $ZOOZ $ALVO crash hard! Which mover has the juice for tomorrow? The volume tells a crazy story https://stocksrunner.com/news/2025-11-03-movers-and-shakers-rally-hard-while-others-crash-today
1 · Reply
topstockalerts
topstockalerts Nov. 3 at 5:32 PM
$MD Stay tuned for more! 💪
0 · Reply
briefingcom
briefingcom Nov. 3 at 1:44 PM
$MD: Pediatrix Medical Group (+16.1%) beats by $0.20, beats on revs; raises FY25 adjusted EBITDA guidance https://www.briefing.com/in-depth-analysis/content/article?ArticleId=IN20251103060419MD&utm_campaign=inplay&utm_medium=social&utm_source=st&utm_content=view_page
0 · Reply
briefingcom
briefingcom Nov. 3 at 1:31 PM
Gapping up in reaction to earnings/guidance: $MD +16% $CMPO +12.9% $LQDA +11.6% $FRPT +10.4% $IDXX +7.6%
0 · Reply
DonCorleone77
DonCorleone77 Nov. 3 at 11:29 AM
$MD Pediatrix Medical reports Q3 adjusted EPS 67c, consensus 47c -- Q3 revenue $493M, consensus $476.44M. -- Raises FY25 adjusted EBITDA view to $270M-$290M , prior view was FY25 adjusted EBITDA $245M-$255M.
0 · Reply
Estimize
Estimize Nov. 2 at 7:00 PM
$MD reports before the open tomorrow, Estimize Consensus +0.04 EPS and +3.54M Revs compared to WS http://www.estimize.com/md/fq3-2025?utm_c
0 · Reply
ZacksResearch
ZacksResearch Oct. 30 at 6:50 PM
$MD faces a critical Q3 — can cost cuts save the bottom line? With revenues slipping, the key test is whether lower expenses are enough to keep earnings momentum intact. Find out what’s at stake for $MD this quarter 👉 https://www.zacks.com/stock/news/2781872/pediatrix-medicals-q3-test-can-lower-expenses-drive-earnings?cid=sm-stocktwits-2-2781872-teaser-18673&ADID=SYND_STOCKTWITS_TWEET_2_2781872_TEASER_18673
0 · Reply
ZacksResearch
ZacksResearch Oct. 30 at 5:50 PM
$MD earnings preview: Will it continue its past performance? 🤔 📊 EPS estimate stable at 46 cents, with 4.6% YoY growth projected. 📉 Revenue expected to drop 5.3% YoY to $484.1M. ⚠️ Zacks Rank #3 & 0.00% Earnings ESP = no clear beat signal this time. Explore the full Q3 outlook here 👉 https://www.zacks.com/stock/news/2781872/pediatrix-medicals-q3-test-can-lower-expenses-drive-earnings?cid=sm-stocktwits-2-2781872-body-18631&ADID=SYND_STOCKTWITS_TWEET_2_2781872_BODY_18631
0 · Reply
TalkMarkets
TalkMarkets Oct. 27 at 9:44 AM
US Stock Indices Set Price Records Amid Soft Inflation Data $IBM $MD $NDX $SPX $DJI https://talkmarkets.com/content/commodities/us-stock-indices-set-price-records-amid-soft-inflation-data?post=530637&userid=166882
0 · Reply
osazuwaosa
osazuwaosa Oct. 14 at 4:44 PM
0 · Reply
ShadedFlicker
ShadedFlicker Oct. 5 at 11:29 AM
$MD Healthcare technology growth. Testing resistance level. Volume confirmation needed. Sector momentum building.
0 · Reply